Evidence map›Paper›PMID 40677403›Full record

ArticleMaterials today. Bio2025

Timp2-modified gelatinhydroxyphenylpropionic acid hydrogels reverse enhanced scleral recovery and suppress myopia development in mice.

Kaiqi Liu, Ting Li, Lingwen Gu, Zhenyu Jiang, Jing Jiang, Xi Yang, Yang Zhou, Xiao Feng, Qianqian Gong, Lihua Zhao and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kaiqi LiuDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Ting LiDepartment of Ophthalmology, The Qingdao University Affiliated Women and Children's Hospital, Qingdao, 266011, China.
Lingwen GuDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Zhenyu JiangSchool of Integrated Circuits, Shandong University, Jinan, 250101, China.
Jing JiangThe Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Xi YangQingdao Hospital, Peking University People's Hospital, Qingdao, 266111, China.
Yang ZhouZhengda Guangming International Eye Research Center, Qingdao University, Qingdao, 266012, China.
Xiao FengDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Qianqian GongOphthalmology Center, The Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, 261031, China.
Lihua ZhaoDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Yiming ChenDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Chao YangCollege of Materials Science and Engineering, Qingdao University, Qingdao, 266071, China.
Tao JiangDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel therapeutic strategy for form deprivation myopia (FDM) involving Timp2-modified scleral stem cells (SSC

Indexed as

Form deprivation myopiaHydrogelMyopia treatmentScleral recoveryScleral stem cellsTimp2

Identifiers

PMID40677403
PMCPMC12268941

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.